论文部分内容阅读
1994年5月以来,我们采用日本山之内制药株式会社生产的法莫替丁(商品名高舒达,Gaster)静滴,并以甲氰咪胍作为对照,共观察120例患者,就其疗效、副作用进行对比。 1 资料与方法 1.1 一般资料 全部患者男75例,女45例,年龄最大82岁,最小15岁,平均48岁,均因黑便和/或呕血急诊入院,大部分患者有头晕、脉速表现。但均无休克,入院前未经特殊治疗,其中70例患者有胃痛史。全部患者均经胃镜或上消化道钡餮检查确诊病因(见表1),平均出血量(估计)1000ml,平均血色素73±12g/L,经治疗无1例死亡。
Since May 1994, we have adopted intravenous drip of famotidine (Gostoside) manufactured by Japan’s Yamanouchi Pharmaceutical Co., Ltd., and controlled trials with cimetidine. A total of 120 patients were observed, and their efficacy, Side effects were compared. 1 Materials and Methods 1.1 General Information All patients were 75 males and 45 females, the oldest 82 years old, the youngest 15 years old, average 48 years old, were due to melena and / or hematemesis emergency admission, most patients have dizziness, pulse speed performance . But no shock, without special treatment before admission, of which 70 patients had a history of stomach pain. All patients were diagnosed by endoscopy or upper gastrointestinal barium (see Table 1), the average amount of bleeding (estimated) 1000ml, the average hemoglobin 73 ± 12g / L, no death after treatment.